Posted on October 25, 2004
- 2004P-0059: HEALTH CLAIM PETITION:
GLUCOSAMINE AND CHONDROITIN SULFATE AND OSTEOARTHRITIS
- Posted CP1, ACK1, SUP1 -3, LET1-7, LET1-5, PDN1, MM1, MT1, ANS1
- 2004Q-0100: Qualified Health Claim
(QHC) Calcium and Bone Fractures
- 2004N-0214: PUBLIC INFORMATION REGULATIONS
- Posted EC1, EMC1, 2, NPR1, NFR1
- 2004Q-0098: Qualified Health Claim:
Calcium and Hypertension
- 2004P-0060: HEALTH CLAIM PETITION:
GLUCOSAMINE SULFATE AND OSTEOARTHRITIS
- Posted CP1, EXT1, LET1-10, PDN1, SUP1, EMC1
- 2004Q-0099: QUALIFIED HEALTH CLAIM:
CALCIUM AND MENSTRUAL DISORDERS
Posted on October 21, 2004
- 2004Q-0097: Qualified Health Claim
(QHC) Calcium and Cancer
- Posted ANS1, C1, EC1, EXT1, LET3-4
- 1995S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
Posted on October 19, 2004
- 2004Q-0144: Qualified Health Claim
(QHC): Chromium Picolinate and Diabetes
- 2004Q-0102: Qualified Health Claim
(QHC) Calcium and Kidney/Urinary Stones
- 2004P-0297:
NUTRIENT CONTENT CLAIM: DEFINE TERMS LOW CARBOHYDRATE, REDUCED CARBOHYDRATE
AND CARBOHYDRATE FREE
Posted on October 5, 2004
- 2003P-0274:: IN RE TIER 1 INITIAL
APPROVAL PROGRAM
- 2004F-0374: AMEND FOOD ADDITIVE
REGULATIONS IN 172.380 VITAMIN D3 TO PERMIT THE USE OF VITAMIN D3 IN
CHEESE AND CHEESE PRODUCTS AT A LEVEL ABOVE THAT PERMITTED UNDER 184.1950
VITAMIN D
- 2004D-0283: WAIVERS OF IN VIVO DEMONSTRATION
OF BIOEQUIVALENCE OF ANIMAL DRUGS IN SOLUBLE POWDER ORAL DOSAGE FORM
PRODUCTS AND TYPE A MEDICATED ARTICLES
- 2004N-0355: SCIENTIFIC CONSIDERATIONS
RELATED TO DEVELOPING FOLLOW-ON PROTEIN PRODUCTS
- Posted EMC1, EC1-8, C1, NCR1, NM1
Posted on October 4, 2004
- 2004N-257: Recordkeeping Requirements
for Human Food and Cosmetics Manufactured from Processed with, or Otherwise
Containing Material from Cattle
- Posted BKG1, C1-15, EMC1-18, EC1-2, REF1,
NPR1
Posted on September 28, 2004
- 2003N-0312: Discussion of Animal
Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program
for the Manufacture and Distribution of Animal Feeds
Posted on September 27, 2004
- 2004S-0170: Medicare Prescription
Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggest
Priority Topics for Research
Posted on September 24, 2004
Posted on September 21, 2004
- 2004S-0212: Pandemic Influenza Preparedness
and Response Plan
Posted on September 16, 2004
- 95S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
Posted on September 15, 2004
- 2004S-0233: Stimulating Innovation
in Medical Techologies
- Posted BKG1, C1-17, EC1-15, EMC11-4, N1
- 2004N-0330: Suicidality in Clinical
Trials for Antidepressant Drugs in Pediatric Patients
- Posted NM1, NCR1, SUP1, C1-2, EC1-21, TS1-2
- 2004N-0337: Subpart D IRB Referral,
Effects of a Single Dose of Dextroamphetamine in Attention Deficit Hyperactivity
Disorder; a Functional Magnetic Resonance Study
- 2004N-0221: Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 Section 107(F) B
- Posted N1, EMC1-24, EC1-25, LET1
Posted on September 13, 2004
- 2004N-0133: Part II, Electronic
Record; Electronic Signatures; Public Meeting
Posted on September 8, 2004
- 2004N-0181: Critial Path Initiative
- Posted C1-59, EC1-39, EMC1-16
Posted on August 30, 2004
- 2002N-0278: Section 307: Bioterrorism
Preparedness; Prior Notice of Imported Food Shipment
Posted on August 9, 2004
- 2002N-0278: Section 307: Bioterrorism
Preparedness; Prior Notice of Imported Food Shipment
- Posted C323-364, EMC202-226, EC484-505, EXT2 &3, CR2,
- 2004S-0270: Notice Announcing Publication
of the Report to Congress Entitled "Plan for the Transfer of Responsibility
for Medicare Appeals" and Soliciting Comments
- 1995S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
- Posted RPT201 through RPT220
Posted on July 20, 2004
- 1994N-0012: Methods of the Allergenic
Products Testing Laboratory
- 1995S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
- Posted RPT197 through RPT200
Posted on July 15, 2004
- 95S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
- Posted RPT192 through RPT196
- 2004N-0033: Factor VIII Inhibitors,
Public Workshop
Posted on July 13, 2004
- 95S-0316: 75-Day Premarket Notifications
for New Dietary Ingredients
- Posted RPT189 through RPT191
- 2004N-0115: Prescription Drug Importation;
Public Meeting
- 2004Q-0151: Qualified Health Claim
(QHC): Soy Protein and Cancer
- 2004Q-0180: Qualified Health Claim
(QHC): Lutein and Eye Diseases
- Posted ACK2, EC1-8, 10-12
- 2004S-0170: Medicare
Prescription Drug, Improvement, and Modernization Act of 2003, Section
1013: Suggest Priority Topics for Research
Posted on July 1, 2004
- 2004Q-0201: Qualified Health Claim
(QHC); Lycopene, Tomatoes and Cancer
Posted on June 29, 2004
- 2004N-0133: Part II, Electronic
Record; Electronic Signatures; Public Meeting
- Posted C1-9, EC1-17, EMC1-41, LET1, NM1
Posted on June 9, 2004
- 2002N-0278: 02N-0278: Bioterrorism
Preparedness: Prior Notice of Imported Food Shipments
- Posted EC386-484, EMC165-201, C294-331, NAD3, NEC1, EXT1
Posted on June 8, 2004
- 2004N-0115: Prescription Drug Importation;
Public Meeting
|